OECD Guidelines for the Testing of Chemicals, Section 4

Health Effects

ISSN :
2074-5788 (online)
DOI :
10.1787/20745788
Hide / Show Abstract

The OECD Guidelines for the Testing of Chemicals is a collection of about 100 of the most relevant internationally agreed testing methods used by government, industry and independent laboratories to identify and characterise potential hazards of new and existing chemical substances, chemical preparations and chemical mixtures. They are a set of tools for professionals, used primarily in regulatory safety testing and subsequent chemical and chemical product notification and chemical registration. They can also be used for the selection and ranking of candidate chemicals during the development of new chemicals and products and in toxicology research. This group of tests covers health effects.

Also available in: French
 
Test No. 410: Repeated Dose Dermal Toxicity: 21/28-day Study

Test No. 410: Repeated Dose Dermal Toxicity: 21/28-day Study You or your institution have access to this content

Click to Access: 
    http://oecd.metastore.ingenta.com/content/9741001e.pdf
  • PDF
  • http://www.keepeek.com/Digital-Asset-Management/oecd/environment/test-no-410-repeated-dose-dermal-toxicity-21-28-day-study_9789264070745-en
  • READ
Author(s):
OECD
Publication Date :
12 May 1981
Pages :
8
ISBN :
9789264070745 (PDF)
DOI :
10.1787/9789264070745-en

Hide / Show Abstract

This study relates to the analysis, via dermal application, of the health hazard of solid or liquid test substance.

This method is composed of two tests: the main test and the limit test. This Test Guideline is intended for use with the adult rat, rabbit or guinea pig. At least 10 animals (5 female and 5 male) with healthy skin should be used at each dose level (at least three). The highest dose level should result in toxic effects but not produce an incidence of fatalities. The limit test corresponds to one dose level of at least 1000 mg/kg body weight. The method is based on the repeated application of the substance of interest during one limited period (several hours daily during 21/28 days). The test substance should be applied over not less than 10 per cent of the body surface area. The results of this study include: measurements and daily and detailed observations (haematology, clinical biochemistry and urinalysis), as well as gross necropsy and histopathology. A properly conducted 21-day or 28-day study should provide information on the effects of repeated inhalation exposure and can indicate the need for further longer term studies and provide information on the dose levels of the latter.

Also available in: French